1. Home
  2. ZLAB vs SNDR Comparison

ZLAB vs SNDR Comparison

Compare ZLAB & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SNDR
  • Stock Information
  • Founded
  • ZLAB 2013
  • SNDR 1935
  • Country
  • ZLAB China
  • SNDR United States
  • Employees
  • ZLAB N/A
  • SNDR N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SNDR Trucking Freight/Courier Services
  • Sector
  • ZLAB Health Care
  • SNDR Industrials
  • Exchange
  • ZLAB Nasdaq
  • SNDR Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • SNDR 4.2B
  • IPO Year
  • ZLAB 2017
  • SNDR 2017
  • Fundamental
  • Price
  • ZLAB $34.55
  • SNDR $23.71
  • Analyst Decision
  • ZLAB Buy
  • SNDR Buy
  • Analyst Count
  • ZLAB 4
  • SNDR 13
  • Target Price
  • ZLAB $47.37
  • SNDR $27.31
  • AVG Volume (30 Days)
  • ZLAB 1.0M
  • SNDR 657.1K
  • Earning Date
  • ZLAB 08-05-2025
  • SNDR 07-31-2025
  • Dividend Yield
  • ZLAB N/A
  • SNDR 1.60%
  • EPS Growth
  • ZLAB N/A
  • SNDR N/A
  • EPS
  • ZLAB N/A
  • SNDR 0.71
  • Revenue
  • ZLAB $418,326,000.00
  • SNDR $5,373,300,000.00
  • Revenue This Year
  • ZLAB $44.07
  • SNDR $10.86
  • Revenue Next Year
  • ZLAB $49.13
  • SNDR $6.04
  • P/E Ratio
  • ZLAB N/A
  • SNDR $33.37
  • Revenue Growth
  • ZLAB 43.72
  • SNDR N/A
  • 52 Week Low
  • ZLAB $16.01
  • SNDR $20.59
  • 52 Week High
  • ZLAB $44.34
  • SNDR $33.90
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.05
  • SNDR 48.78
  • Support Level
  • ZLAB $36.36
  • SNDR $23.79
  • Resistance Level
  • ZLAB $44.34
  • SNDR $24.51
  • Average True Range (ATR)
  • ZLAB 1.45
  • SNDR 0.56
  • MACD
  • ZLAB -0.16
  • SNDR -0.06
  • Stochastic Oscillator
  • ZLAB 39.20
  • SNDR 32.88

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SNDR Schneider National Inc.

Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.

Share on Social Networks: